Delivery Order SPE2DB25D3404-SPE2DB25FUNWC
Award Date
6/16/25
Potential Completion Date
7/9/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,100.15, is for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 time period, with an ultimate completion date of April 24, 2025. The contract is a firm-fixed-price arrangement and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a...
This federal contract award is for the delivery of Pfizer COVID-19 vaccines for the years 2024-2025, with a contract ceiling value of $2,271.56. The contract was awarded to the prime contractor, AmerisourceBergen Drug Corp, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation. The contract supports the federal government's ongoing COVID-19 vaccination efforts, providing 0.9 mL...
This federal contract award, valued at $1,100.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pfizer COVID-19 vaccines from 2024 to 2025. The contract is a Firm Fixed Price Delivery Order with a completion date of May 21, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDQB2, is for the delivery of Pfizer COVID-19 vaccines for the 2024-2025 time period, with a potential value of $7,125.69. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, with Amerisourcebergen Drug Corp, a major pharmaceutical distributor, as the prime contractor. The contract is for the delivery of 0.9 mL EUA (Emergency Use Authorization) COVID-19 vaccines and does not have a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.9 ML doses of the Pfizer COVID-19 vaccine for the 2024-2025 timeframe, including the Emergency Use Authorization (EUA) period. The contract has a ceiling value of $1,100.15 and is a Firm Fixed Price Delivery Order with a period of performance through March 26, 2025. The contract is...
This federal contract award is for the delivery of 0.9mL COVID-19 vaccines from Pfizer to the Defense Logistics Agency (DLA) from September 2024 through September 2025. The contract, valued at $1,135.77, is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. There was no set-aside used for this award. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 time period. The award, valued at $1,092.06, is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This is a $1,100.15 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Pfizer COVID-19 vaccine doses in 2024-2025, with a period of performance through July 1, 2025. This contract is not set aside and was open to full and open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 indefinite delivery contract with the DLA for global pharmaceutical...
This federal contract award, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, is for the delivery of Pfizer COVID-19 vaccines in the 2024-2025 timeframe. The $1,129.80 firm fixed-price delivery order has an ultimate completion date of January 13, 2025 and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is delivering these COVID-19 vaccines to support military healthcare programs globally through the company's existing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pfizer COVID-19 vaccines for the 2024-2025 period under an Emergency Use Authorization (EUA). The contract has a ceiling value of $1,622.03 and an ultimate completion date of March 11, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...